A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure

NCT07584967 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions

DRUG: AC01
OTHER: Placebo

Sponsor

AnaCardio AB